Importance of Bone Targeting Agents in Metastatic Breast Cancer

Featured Speakers

Francis Arena, MD, FACP

Oncologist, Clinical Investigator, Educator

NYU Langone Arena Oncology

New York, NY

Noam Drazin, MD

Medical Oncology

Cedars Sinai Medical Group

Beverly Hills, CA

Program Learning Objectives

• Understand breast cancer patient perspective regarding her bones and treatment for prevention of skeletal-related events.
• Describe the devastating consequences of bone metastases and the subsequent bone complications* that can occur in patients with breast cancer
• Discuss treatment options for prevention of bone complications in breast cancer patients with bone metastases
• Understand which BTA was proven superior in the prevention of skeletal related events during robust clinical trials
• Review real world data on appropriate dosing of BTAs in patients with breast cancer and bone metastases

REGISTER NOW!